​

Dynavax (DVAX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

DVAX Stock Forecast

Dynavax (DVAX) stock forecast, based on 3 Wall Street analysts, predicts a 12-month average price target of $24.50, with a high of $29.00 and a low of $20.00. This represents a 88.75% increase from the last price of $12.98.

$10 $14 $18 $22 $26 $30 High: $29 Avg: $24.5 Low: $20 Last Closed Price: $12.98

DVAX Stock Rating

Dynavax stock's rating consensus is Buy, based on 3 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (66.67%), 1 Hold (33.33%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 3 1 2 0 Strong Sell Sell Hold Buy Strong Buy

DVAX Forecast vs Benchmarks

TypeNameUpside
StockDynavax88.75%
SectorHealthcare Stocks 25.20%
IndustrySpecialty & Generic Drug Manufacturers Stocks24.78%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$24.50
Last Closing Price$12.98$12.98$12.98
Upside/Downside--88.75%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25221--5
Dec, 24221--5
Nov, 24251--8
Oct, 24251--8
Sep, 24251--8
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 28, 2024Edward WhiteH.C. Wainwright$29.00$11.37155.06%123.42%
May 14, 2024Paul ChoiGoldman Sachs$20.00$11.0081.82%54.08%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Jan 14, 2025H.C. WainwrightBuyBuyhold
Oct 15, 2024H.C. WainwrightBuyBuyhold
Jun 28, 2024H.C. WainwrightBuyBuyhold
May 14, 2024Goldman SachsNeutralNeutralhold
May 14, 2024H.C. WainwrightBuyBuyhold
Feb 24, 2023JMP SecuritiesMarket OutperformMarket Outperformhold
Sep 27, 2022JMP SecuritiesOutperforminitialise

Financial Forecast

EPS Forecast

$-50 $-39 $-28 $-17 $-6 $5 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.90$0.62$2.91$-49.63-----
Avg Forecast$-0.87$0.45$1.91$-0.13$0.20$0.27$0.51$0.71$1.00
High Forecast$-0.92$0.43$1.86$-0.31$0.16$0.23$0.47$0.64$0.98
Low Forecast$-0.83$0.48$1.96$-0.04$0.25$0.29$0.57$0.75$1.02
Surprise %3.45%37.78%52.36%38076.92%-----

Revenue Forecast

$0 $150M $300M $450M $600M $750M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$46.55M$439.44M$722.68M$232.28M-----
Avg Forecast$40.06M$449.44M$717.80M$229.42M$278.12M$333.51M$386.49M$464.32M$585.00M
High Forecast$38.80M$435.23M$704.07M$227.30M$278.00M$333.47M$386.49M$464.32M$575.93M
Low Forecast$41.82M$469.13M$733.21M$231.54M$278.23M$333.54M$386.49M$464.32M$595.70M
Surprise %16.19%-2.22%0.68%1.25%-----

Net Income Forecast

$-100M $10M $120M $230M $340M $450M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-91.78M$76.71M$293.16M$-6.39M-----
Avg Forecast$-64.66M$103.14M$343.48M$-6.39M$26.91M$33.57M$70.07M$89.56M$128.77M
High Forecast$-81.08M$73.41M$264.78M$-7.86M$21.00M$29.24M$60.30M$82.47M$126.18M
Low Forecast$-48.24M$132.86M$422.19M$-4.92M$32.81M$37.91M$73.69M$96.65M$131.83M
Surprise %41.93%-25.62%-14.65%------

DVAX Forecast FAQ

Is Dynavax stock a buy?

Dynavax stock has a consensus rating of Buy, based on 3 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Dynavax is a favorable investment for most analysts.

What is Dynavax's price target?

Dynavax's price target, set by 3 Wall Street analysts, averages $24.5 over the next 12 months. The price target range spans from $20 at the low end to $29 at the high end, suggesting a potential 88.75% change from the previous close price of $12.98.

How does Dynavax stock forecast compare to the average forecast of its sector, industry, and investment themes?

Dynavax stock forecast shows a 88.75% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the specialty & generic drug manufacturers stocks industry (24.78%).

What is the breakdown of analyst ratings for Dynavax over the past three months?

  • January 2025: 40.00% Strong Buy, 40.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 40.00% Strong Buy, 40.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 25.00% Strong Buy, 62.50% Buy, 12.50% Hold, 0% Sell, 0% Strong Sell.

What is Dynavax’s EPS forecast?

Dynavax's average annual EPS forecast for its fiscal year ending in December is 0.2 for 2024, a -100.40% decrease from the reported $-49.63 in 2023. The prediction for 2025 is $0.27, $0.51 for 2026, $0.71 for 2027, and $1 for 2028.

What is Dynavax’s revenue forecast?

Dynavax's average annual revenue forecast for its fiscal year ending in December is $278.12M for 2024, a 19.73% increase from the reported $232.28M in 2023. The forecast for 2025 is $333.51M, $386.49M for 2026, $464.32M for 2027, and $585M for 2028.

What is Dynavax’s net income forecast?

For its fiscal year ending in December, Dynavax's average annual net income forecast is $26.91M for 2024, reflecting a -521.12% decrease from the reported $-6.389M in 2023. The projection for 2025 is $33.57M, $70.07M for 2026, $89.56M for 2027, and $128.77M for 2028.